SCHEMBL19786586

SCHEMBL19786586

c1ccc(-n2c3ccccc3c3c4c5ccc6ccccc6c5n(-c5ccc(C6(c7ccccc7)c7ccccc7-c7ccccc76)cc5)c4c4ccccc4c32)cc1

nearest known ligand 0.34

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.34
ATM Q13315 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
MEN1 O00255 1/20 0.34
LMNA P02545 1/20 0.34
MAPT P10636 1/20 0.34
OPRK1 P41145 1/20 0.34
KMT2A Q03164 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19786585 0.85 KDM4E (0.35) KDM4EATML3MBTL1
SCHEMBL19786513 0.84 KDM4E (0.47) KDM4EATML3MBTL1MEN1MAPT
SCHEMBL10029957 0.83 KDM4E (0.47) KDM4EATML3MBTL1MEN1LMNA
SCHEMBL19786514 0.83 KDM4E (0.31) KDM4EATML3MBTL1
SCHEMBL19786740 0.82 CDK4 (0.40) KDM4EMEN1LMNAMAPTOPRK1
SCHEMBL17805082 0.81 KDM4E (0.32) KDM4EATML3MBTL1MEN1LMNA
SCHEMBL12104914 0.81 KDM4E (0.38) KDM4EATML3MBTL1MEN1LMNA
SCHEMBL16485012 0.80 KDM4E (0.37) KDM4EATML3MBTL1MEN1LMNA
SCHEMBL19786668 0.80 KDM4E (0.40) KDM4EATML3MBTL1MEN1KMT2A
SCHEMBL17299428 0.80 KDM4E (0.39) KDM4EATML3MBTL1MEN1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190300535-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC DEVICE USING SAME, AND ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2019-10-03 US disclosed
WO-2018012781-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC DEVICE USING SAME, AND ELECTRONIC DEVICE THEREOF 덕산네오룩스 주식회사 2018-01-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190300535-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC DEVICE USING SAME, AND ELECTRONIC DEVICE THEREOF ORC3, OR51E2, ORAI2 KDM4E 442/4885ATM 3467/4885L3MBTL1 1707/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.